302 related articles for article (PubMed ID: 29359185)
1. Antibiotic Treatments for
Lamendella R; Wright JR; Hackman J; McLimans C; Toole DR; Bernard Rubio W; Drucker R; Wong HT; Sabey K; Hegarty JP; Stewart DB
mSphere; 2018; 3(1):. PubMed ID: 29359185
[No Abstract] [Full Text] [Related]
2. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
[TBL] [Abstract][Full Text] [Related]
3. Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection.
Džunková M; Moya A; Vázquez-Castellanos JF; Artacho A; Chen X; Kelly C; D'Auria G
mSphere; 2016; 1(3):. PubMed ID: 27303742
[TBL] [Abstract][Full Text] [Related]
4. Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.
Sangster W; Hegarty JP; Schieffer KM; Wright JR; Hackman J; Toole DR; Lamendella R; Stewart DB
Front Microbiol; 2016; 7():789. PubMed ID: 27252696
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
[TBL] [Abstract][Full Text] [Related]
7. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
8. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
9. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.
Antharam VC; Li EC; Ishmael A; Sharma A; Mai V; Rand KH; Wang GP
J Clin Microbiol; 2013 Sep; 51(9):2884-92. PubMed ID: 23804381
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
Cornely OA
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of Clostridium difficile infection.
Dupont HL
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
[TBL] [Abstract][Full Text] [Related]
13. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
[TBL] [Abstract][Full Text] [Related]
14. Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by
Kulecka M; Zeber-Lubecka N; Bałabas A; Czarnowski P; Bagińska K; Głowienka M; Kluska A; Piątkowska M; Dąbrowska M; Waker E; Mikula M; Ostrowski J
Front Cell Infect Microbiol; 2023; 13():1190910. PubMed ID: 37577378
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
17. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
[TBL] [Abstract][Full Text] [Related]
18. Breakthroughs in the treatment and prevention of Clostridium difficile infection.
Kociolek LK; Gerding DN
Nat Rev Gastroenterol Hepatol; 2016 Mar; 13(3):150-60. PubMed ID: 26860266
[TBL] [Abstract][Full Text] [Related]
19. Advances in the Microbiome: Applications to Clostridium difficile Infection.
Culligan EP; Sleator RD
J Clin Med; 2016 Sep; 5(9):. PubMed ID: 27657145
[TBL] [Abstract][Full Text] [Related]
20.
Jenior ML; Leslie JL; Young VB; Schloss PD
mSystems; 2017; 2(4):. PubMed ID: 28761936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
